Atara Biotherapeutics (ATRA) Return on Sales Growth (3y) (2024 - 2026)

Atara Biotherapeutics (ATRA) Return on Sales Growth (3y) (2024 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Nanobiotix 1,799.45 Bn 1,799.39 Bn - -
2 Akari Therapeutics 994.00 Bn 994.00 Bn - -
3 BeOne Medicines 472.71 Bn 467.91 Bn 1.35 Bn 1.00
4 Vertex Pharmaceuticals 124.82 Bn 117.58 Bn 2.59 Bn 0.00
5 Regeneron Pharmaceuticals 71.80 Bn 63.05 Bn 3.31 Bn 0.00
6 Belite Bio 61.76 Bn 61.76 Bn - -
7 Argenx Se 54.26 Bn 49.08 Bn 1.41 Bn 1.00
8 Alnylam Pharmaceuticals 38.12 Bn 35.11 Bn 959.66 Mn 1.00
9 Revolution Medicines 36.29 Bn 36.29 Bn - -
10 Atara Biotherapeutics 105.19 Mn 96.83 Mn 392,000.00 77.00

Historic Data

Download Data
DateValue
Mar 31, 2026 77.00
Dec 31, 2025 40.00
Sep 30, 2025 18.00
Jun 30, 2025 0.00
Mar 31, 2025 21.00
Dec 31, 2024 12.00
Sep 30, 2024 15.00
Jun 30, 2024 21.00
Mar 31, 2024 21.00